Aktivitet

Hur dödar B17 Cancerceller?

B-17 dialog

Våra kroppar använder enzymer för att utföra många olika uppgifter och ett särskilt enzym som kallas Rhodanese finns i stora mängder i hela kroppen. Rhodanese finns dock inte där det finns cancerceller. Däremot innehåller cancerceller ett enzym som kallas beta-glucosidase som inte finns någon annanstans i kroppen än i cancerceller.

Vitamin B17 består av 2 delar glukos, 1 del Vätecyanid och 1 del Bensaldehyd (smärtstillande). När B17 tillförs I kroppen bryts det ned av enzymet Rhodanese. Rhodanese bryter Vätecyanid och Bensaldehyd i 2 biprodukter; Thiocyanate och bensoesyra som gynnar friska celler. Eventuellt överskott av dessa biprodukter försvinner genom urinet. Vitamin B17 passerar genom kroppen och stannar inte längre än 80 minuter eftersom Rhodanese bryter ned det.

När B17 kommer i kontakt med cancerceller (där det inte finns Rhodanese som bryter ned det utan istället enzymet beta-Gucosidase) inträffar en kemisk reaktion där Vätecyanid och Bensaldehyd producerar ett gift som förstör och dödar cancercellerna.

Hela denna process kallas selektiv toxicitet där endast cancercellerna förstörs. Se diagrammet nedan.

Detta har bevisats och illustrerats av de främsta specialister i världen. Därför har Contreras sjukhus i Mexiko och Harold Manner sjukhus framgångsrikt behandlat 100.000 patienter de senaste 30 åren.

FDA (Amerikanska Food and Drug Administration) har tidigare bett ett team av världens främsta cancerspecialister och biologiska kemister att genomföra tester för att se om Laetrile kan döda cancerceller. Gruppen kom fram till att det dödade cancer och blev sedan avskedade och resultaten mörklagt.

B-17 dialog

B-17 dialog

Testimonials

Dr. Hans Nieper, a cancer specialist from West Germany quoted in the US

  • Former Director of the Department of Medicine at Silbersee Hospital in Hanover
  • Former Head of Aswchaffenburg Hospital Laboratory
  • Former Director of the German Society for Medicine Tumor Treatment
  • Pioneer cobalt therapy and the anti-cancer drug cylcophosphamide

“After more than 20 years of such specialized work, I have found the non-toxic nitrilosides, that is, far superior to any other known cancer treatment or preventive. In my opinion, it is the only existing possibility for the ultimate control of all cancers.”


Dr. Ernesto Contreras, a cancer specialist from Oasis Hospital, Mexico, treated 100,000 cancer patients

  • Operated the Oasis Hospital in Tijuana, Mexico
  • Chief pathologist at the Army Hospital in Mexico City
  • Professor of Histology and Pathology at the Mexican Army Medical School
  • Cancer specialist for over 30 years, treating cancer patients with vitamin B17

“For the prevention of cancer and the maintenance of remission, there is nothing as effective as B17… its non-toxicity permits of its use indefinitely, while surgery, radiation and chemotherapy can only be administered for a limited time……the majority of cancers that occur more frequently, such as cancers of the lungs, breast, colon, ovaries, stomach, esophagus, prostate and the lymphomas, are much helped by B17.”


Dr. Dean Burk, one of the foremost cancer specialists in the world

  • Ph. D. in Biochemistry at the University of California
  • A founding member of the American Federal Government’s National Cancer Institute (NCI)
  • Head of Cytochemistry Section of NCI
  • Gerhard Domagk Award for Cancer Research
  • Hillebrand Award of the American Chemistry Society
  • The Commander Knighthood of the Medical Order of Bethlehem (Rome)
  • Fellow of The National Research Council at the University of London
  • Senior chemist at NCI
  • Author of 3 books on Chemotherapy Cancer Research
  • Author of more than 200 scientific papers in the field of cell chemistry

“When we add B17 to a cancer culture under the microscope, we can see the cancer cells dying off like flies.”


Dr. Ernst T. Krebs Jr. Ph.D. , (The Discoverer of vitamin B17) had convinced the world that B17 is the first and final hope in therapy of cancer in man and animals. Below is part of his speech with strong messages presented at the 2nd Annual Cancer Convention at the Ambassador Hotel in LA, California, USA. “We hear a great deal about its use in terminal cancer, but the time to start with B17 is NOW before the disease become clinical. You may start right now by commencing to eat proper quantity of B17 through ingesting nitrilosides rich in B17. We will be able to prevent this disease just as surely as we are able to prevent scurvy by the use of vitamin C…”


Dr. Kanematsu Sugiura, one of the world’s most respected and experienced Japanese cancer research scientists, with over 60 years’ experienced in cancer research to his credit, had headed for a 5-year research (1972-1977) on B17 at Memorial Sloan Kettering in New York. In science laboratory, he was the perfect man for this test. His findings were regarded as final by the Russian cancer researchers. He reported,
“B17 is effective in stopping metastasis (spreading) of cancer.”

As it turned out, Dr. Lloyd Schloen, who duplicated Sugiura’s experiments, had gone so far to add proteolytic enzymes to the injections, and reported a 100% cure rate among Swiss albino mice.


Dr. Philip E. Binzel, Jr., a physician in Washington Court House, Ohio who has used B17 for cancer treatments for over 20 years with astounding success from his medical establishment. He cited, “If you are tumor-oriented and are looking for something to make the tumor magically disappear, no, it doesn’t. But, if you are looking for something that will prevent the disease from spreading and save the life of the patient, yes, it does.”


Dr. H.W. Manner, the Chicago Cancer Specialist, announced his breakthrough in cancer research at the National Health Federation Press conference in Chicago “Laetrile (B17) alone won’t do it, but B17 / enzyme / vitamins and minerals destroy cancer.”

References:
1. “World Without Cancer” – G. Eward Griffin
2. “Cancer: Why We’re Still Dying to Know the Truth” – by Philip Day
3. “Alive and Well” – by Dr. Philip E. Binzel, Jr.

Comments